Yılmaz NK. Dasatinib as a Repurposing Candidate for Alzheimer’s Disease: An Integrated In Silico Network Pharmacology and Molecular Docking Study. Trends in Pharmacy [Internet]. 2026 Jun. 24 [cited 2026 Jul. 19];3:1-11. Available from: https://trendsinpharmacy.org/index.php/pub/article/view/68